Europe Attention Deficit Hyperactivity Disorder Market Size, Share & Industry Trends Analysis Report By Drug Type, By Demographics (Adults and Children), By Distribution Channel (Retail Pharmacy and Hospital Pharmacy), By Country and Growth Forecast, 2022 - 2028

The Europe Attention Deficit Hyperactivity Disorder Market would witness market growth of 4.3% CAGR during the forecast period (2022-2028).

In the majority of nations, there exists vast diagnostic categories and threshold differences. These inconsistencies make it difficult for patients to have a sure primary diagnosis. Some countries continue to define ADHD diagnostically, requiring the presence of impulsivity or hyperactivity. Low learning disabilities or working memory would be diagnosed in the inattentive form of ADHD.

Country-specific diagnoses are occasionally linked with cultural perceptions of the behavior and attention anomalies of people with ADHD. How ADHD symptoms are defined is undoubtedly influenced by cultural norms and lifestyle. ADHD is diagnosed in part based on information provided by parents and teachers. Their expectations or opinions of what is typical, frequently based on cultural factors, have an impact on that reporting.

However, the symptoms of ADHD are essentially similar for all kids and teenagers, regardless of their gender or age. Studies on neurocognition, neurophysiology, and neuroimaging point to the involvement of brain dysfunctions in the main elements of the condition in adults and children. Both dysfunctions of the frontostriatal and increased dopamine transporter density in the striatum have been observed.

In this region, the importance of diagnosing and treating ADHD is rising. This is prevalent mainly in parents that have children with ADHD. Additionally, this recognition of ADHD is comparatively new throughout the region, and therefore, many adults with ADHD who have never been diagnosed can be found in the region as well. A similar pattern is seen among healthcare practitioners, many of whom remain oblivious to the progression of ADHD into adulthood. As a result, the number of awareness initiatives is also increasing throughout the region. In the UK, the guidelines for treating individuals with ADHD are set by National Institute for Health and Clinical Excellence (NICE).

The Germany market dominated the Europe Attention Deficit Hyperactivity Disorder Market by Country in 2021; thereby, achieving a market value of $844.7 million by 2028. The UK market is exhibiting a CAGR of 3.5% during (2022 - 2028). Additionally, The France market would experience a CAGR of 5.1% during (2022 - 2028).

Based on Drug Type, the market is segmented into Stimulants and Non-stimulants. Based on Stimulants Type, the market is segmented into Amphetamine, Methylphenidate, Lisdexamfetamine and Dexmethylphenidate. Based on Non-stimulants Type, the market is segmented into Atomoxetine, Guanfacine, Clonidine and Others. Based on Demographics, the market is segmented into Adults and Children. Based on Distribution Channel, the market is segmented into Retail Pharmacy and Hospital Pharmacy. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

Free Valuable Insights: The Global Attention Deficit Hyperactivity Disorder Market will Hit $16.9 Billion by 2028, at a CAGR of 4%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Eli Lilly And Company, Pfizer, Inc. (Global Blood Therapeutics, Inc.), Johnson & Johnson (Johnson & Johnson Services, Inc.), Lupin Limited, Novartis AG, Takeda Pharmaceutical Company Limited, Mallinckrodt PLC, Purdue Pharma L.P., Aytu BioPharma, Inc. and Supernus Pharmaceuticals, Inc.

Scope of the Study

Market Segments Covered in the Report:

By Drug Type

• Stimulants
  • Amphetamine
  • Methylphenidate
  • Lisdexamfetamine
  • Dexmethylphenidate
• Non-stimulants
  • Atomoxetine
  • Guanfacine
  • Clonidine
  • Others

By Demographics

• Adults
• Children

By Distribution Channel

• Retail Pharmacy
• Hospital Pharmacy

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

• Eli Lilly And Company
• Pfizer, Inc. (Global Blood Therapeutics, Inc.)
• Johnson & Johnson (Johnson & Johnson Services, Inc.)
• Lupin Limited
• Novartis AG
• Takeda Pharmaceutical Company Limited
• Mallinckrodt PLC
• Purdue Pharma L.P.
• Aytu BioPharma, Inc.
• Supernus Pharmaceuticals, Inc.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Attention Deficit Hyperactivity Disorder Market, by Drug Type
1.4.2 Europe Attention Deficit Hyperactivity Disorder Market, by Demographics
1.4.3 Europe Attention Deficit Hyperactivity Disorder Market, by Distribution Channel
1.4.4 Europe Attention Deficit Hyperactivity Disorder Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Strategies deployed in Attention Deficit Hyperactivity Disorder Market

Chapter 4. Europe Attention Deficit Hyperactivity Disorder Market by Drug Type
4.1 Europe Stimulants Market by Country
4.2 Europe Attention Deficit Hyperactivity Disorder Market by Stimulants Type
4.2.1 Europe Amphetamine Market by Country
4.2.2 Europe Methylphenidate Market by Country
4.2.3 Europe Lisdexamfetamine Market by Country
4.2.4 Europe Dexmethylphenidate Market by Country
4.3 Europe Non-stimulants Market by Country
4.4 Europe Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
4.4.1 Europe Atomoxetine Market by Country
4.4.2 Europe Guanfacine Market by Country
4.4.3 Europe Clonidine Market by Country
4.4.4 Europe Others Market by Country

Chapter 5. Europe Attention Deficit Hyperactivity Disorder Market by Demographics
5.1 Europe Adults Market by Country
5.2 Europe Children Market by Country

Chapter 6. Europe Attention Deficit Hyperactivity Disorder Market by Distribution Channel
6.1 Europe Retail Pharmacy Market by Country
6.2 Europe Hospital Pharmacy Market by Country

Chapter 7. Europe Attention Deficit Hyperactivity Disorder Market by Country
7.1 Germany Attention Deficit Hyperactivity Disorder Market
7.1.1 Germany Attention Deficit Hyperactivity Disorder Market by Drug Type
7.1.1.1 Germany Attention Deficit Hyperactivity Disorder Market by Stimulants Type
7.1.1.2 Germany Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
7.1.2 Germany Attention Deficit Hyperactivity Disorder Market by Demographics
7.1.3 Germany Attention Deficit Hyperactivity Disorder Market by Distribution Channel
7.2 UK Attention Deficit Hyperactivity Disorder Market
7.2.1 UK Attention Deficit Hyperactivity Disorder Market by Drug Type
7.2.1.1 UK Attention Deficit Hyperactivity Disorder Market by Stimulants Type
7.2.1.2 UK Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
7.2.2 UK Attention Deficit Hyperactivity Disorder Market by Demographics
7.2.3 UK Attention Deficit Hyperactivity Disorder Market by Distribution Channel
7.3 France Attention Deficit Hyperactivity Disorder Market
7.3.1 France Attention Deficit Hyperactivity Disorder Market by Drug Type
7.3.1.1 France Attention Deficit Hyperactivity Disorder Market by Stimulants Type
7.3.1.2 France Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
7.3.2 France Attention Deficit Hyperactivity Disorder Market by Demographics
7.3.3 France Attention Deficit Hyperactivity Disorder Market by Distribution Channel
7.4 Russia Attention Deficit Hyperactivity Disorder Market
7.4.1 Russia Attention Deficit Hyperactivity Disorder Market by Drug Type
7.4.1.1 Russia Attention Deficit Hyperactivity Disorder Market by Stimulants Type
7.4.1.2 Russia Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
7.4.2 Russia Attention Deficit Hyperactivity Disorder Market by Demographics
7.4.3 Russia Attention Deficit Hyperactivity Disorder Market by Distribution Channel
7.5 Spain Attention Deficit Hyperactivity Disorder Market
7.5.1 Spain Attention Deficit Hyperactivity Disorder Market by Drug Type
7.5.1.1 Spain Attention Deficit Hyperactivity Disorder Market by Stimulants Type
7.5.1.2 Spain Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
7.5.2 Spain Attention Deficit Hyperactivity Disorder Market by Demographics
7.5.3 Spain Attention Deficit Hyperactivity Disorder Market by Distribution Channel
7.6 Italy Attention Deficit Hyperactivity Disorder Market
7.6.1 Italy Attention Deficit Hyperactivity Disorder Market by Drug Type
7.6.1.1 Italy Attention Deficit Hyperactivity Disorder Market by Stimulants Type
7.6.1.2 Italy Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
7.6.2 Italy Attention Deficit Hyperactivity Disorder Market by Demographics
7.6.3 Italy Attention Deficit Hyperactivity Disorder Market by Distribution Channel
7.7 Rest of Europe Attention Deficit Hyperactivity Disorder Market
7.7.1 Rest of Europe Attention Deficit Hyperactivity Disorder Market by Drug Type
7.7.1.1 Rest of Europe Attention Deficit Hyperactivity Disorder Market by Stimulants Type
7.7.1.2 Rest of Europe Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
7.7.2 Rest of Europe Attention Deficit Hyperactivity Disorder Market by Demographics
7.7.3 Rest of Europe Attention Deficit Hyperactivity Disorder Market by Distribution Channel

Chapter 8. Company Profiles
8.1 Eli Lilly And Company
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Acquisition and Mergers:
8.2 Pfizer, Inc. (Global Blood Therapeutics, Inc.)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional & Segmental Analysis
8.2.4 Research & Development Expense
8.4 Lupin Limited
8.4.1 Company Overview
8.4.2 Financial Analysis
8.5 Novartis AG
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Approvals and Trials:
8.6 Takeda Pharmaceutical Company Limited
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Research & Development Expense
8.7 Mallinckrodt PLC
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.8 Purdue Pharma L.P.
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Approvals and Trials:
8.9 Aytu BioPharma, Inc.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 Recent strategies and developments:
8.9.5.1 Product Launches and Product Expansions:
8.9.5.2 Approvals and Trials:
8.10. Supernus Pharmaceuticals, Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Research & Development Expenses
8.10.4 Recent strategies and developments:
8.10.4.1 Approvals and Trials:

TABLE 1 Europe Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
TABLE 2 Europe Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
TABLE 3 Europe Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
TABLE 4 Europe Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
TABLE 5 Europe Stimulants Market by Country, 2018 - 2021, USD Million
TABLE 6 Europe Stimulants Market by Country, 2022 - 2028, USD Million
TABLE 7 Europe Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
TABLE 8 Europe Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
TABLE 9 Europe Amphetamine Market by Country, 2018 - 2021, USD Million
TABLE 10 Europe Amphetamine Market by Country, 2022 - 2028, USD Million
TABLE 11 Europe Methylphenidate Market by Country, 2018 - 2021, USD Million
TABLE 12 Europe Methylphenidate Market by Country, 2022 - 2028, USD Million
TABLE 13 Europe Lisdexamfetamine Market by Country, 2018 - 2021, USD Million
TABLE 14 Europe Lisdexamfetamine Market by Country, 2022 - 2028, USD Million
TABLE 15 Europe Dexmethylphenidate Market by Country, 2018 - 2021, USD Million
TABLE 16 Europe Dexmethylphenidate Market by Country, 2022 - 2028, USD Million
TABLE 17 Europe Non-stimulants Market by Country, 2018 - 2021, USD Million
TABLE 18 Europe Non-stimulants Market by Country, 2022 - 2028, USD Million
TABLE 19 Europe Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
TABLE 20 Europe Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
TABLE 21 Europe Atomoxetine Market by Country, 2018 - 2021, USD Million
TABLE 22 Europe Atomoxetine Market by Country, 2022 - 2028, USD Million
TABLE 23 Europe Guanfacine Market by Country, 2018 - 2021, USD Million
TABLE 24 Europe Guanfacine Market by Country, 2022 - 2028, USD Million
TABLE 25 Europe Clonidine Market by Country, 2018 - 2021, USD Million
TABLE 26 Europe Clonidine Market by Country, 2022 - 2028, USD Million
TABLE 27 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 28 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 29 Europe Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
TABLE 30 Europe Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
TABLE 31 Europe Adults Market by Country, 2018 - 2021, USD Million
TABLE 32 Europe Adults Market by Country, 2022 - 2028, USD Million
TABLE 33 Europe Children Market by Country, 2018 - 2021, USD Million
TABLE 34 Europe Children Market by Country, 2022 - 2028, USD Million
TABLE 35 Europe Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 36 Europe Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 37 Europe Retail Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 38 Europe Retail Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 39 Europe Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 40 Europe Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 41 Europe Attention Deficit Hyperactivity Disorder Market by Country, 2018 - 2021, USD Million
TABLE 42 Europe Attention Deficit Hyperactivity Disorder Market by Country, 2022 - 2028, USD Million
TABLE 43 Germany Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
TABLE 44 Germany Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
TABLE 45 Germany Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
TABLE 46 Germany Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
TABLE 47 Germany Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
TABLE 48 Germany Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
TABLE 49 Germany Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
TABLE 50 Germany Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
TABLE 51 Germany Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
TABLE 52 Germany Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
TABLE 53 Germany Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 54 Germany Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 55 UK Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
TABLE 56 UK Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
TABLE 57 UK Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
TABLE 58 UK Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
TABLE 59 UK Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
TABLE 60 UK Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
TABLE 61 UK Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
TABLE 62 UK Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
TABLE 63 UK Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
TABLE 64 UK Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
TABLE 65 UK Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 66 UK Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 67 France Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
TABLE 68 France Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
TABLE 69 France Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
TABLE 70 France Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
TABLE 71 France Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
TABLE 72 France Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
TABLE 73 France Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
TABLE 74 France Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
TABLE 75 France Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
TABLE 76 France Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
TABLE 77 France Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 78 France Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 79 Russia Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
TABLE 80 Russia Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
TABLE 81 Russia Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
TABLE 82 Russia Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
TABLE 83 Russia Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
TABLE 84 Russia Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
TABLE 85 Russia Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
TABLE 86 Russia Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
TABLE 87 Russia Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
TABLE 88 Russia Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
TABLE 89 Russia Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 90 Russia Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 91 Spain Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
TABLE 92 Spain Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
TABLE 93 Spain Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
TABLE 94 Spain Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
TABLE 95 Spain Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
TABLE 96 Spain Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
TABLE 97 Spain Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
TABLE 98 Spain Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
TABLE 99 Spain Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
TABLE 100 Spain Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
TABLE 101 Spain Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 102 Spain Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 103 Italy Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
TABLE 104 Italy Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
TABLE 105 Italy Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
TABLE 106 Italy Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
TABLE 107 Italy Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
TABLE 108 Italy Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
TABLE 109 Italy Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
TABLE 110 Italy Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
TABLE 111 Italy Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
TABLE 112 Italy Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
TABLE 113 Italy Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 114 Italy Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 115 Rest of Europe Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
TABLE 116 Rest of Europe Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
TABLE 117 Rest of Europe Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
TABLE 118 Rest of Europe Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
TABLE 119 Rest of Europe Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
TABLE 120 Rest of Europe Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
TABLE 121 Rest of Europe Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
TABLE 122 Rest of Europe Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
TABLE 123 Rest of Europe Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
TABLE 124 Rest of Europe Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
TABLE 125 Rest of Europe Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 126 Rest of Europe Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 127 Key Information – Eli Lilly And Company
TABLE 128 Key Information – Pfizer, Inc.
TABLE 129 Key Information – Johnson & Johnson (Johnson & Johnson Services, Inc.)
TABLE 130 Key Information – Lupin Limited
TABLE 131 Key Information – Novartis AG
TABLE 132 Key Information – Takeda Pharmaceutical Company Limited
TABLE 133 Key information – Mallinckrodt PLC
TABLE 134 Key Information – Purdue Pharma L.P.
TABLE 135 Key Information – AYTU BIOPHARMA, INC.
TABLE 136 Key Information – Supernus Pharmaceuticals, Inc.

List of Figures
FIG 1 Methodology for the research